After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

Billionaire Airbnb Founder Joe Gebbia Joins Elon Musk At DOGE

Erica Kollmann
March 11, 2025

Joe Gebbia, co-founder of Airbnb, Inc. (NASDAQ:ABNB) and prominent entrepreneur, has joined the Trump administration to serve alongside Elon Musk in the Department of Government Efficiency. 

What To Know:  Gebbia co-founded Airbnb with two friends in 2008 and retains a 7% stake in the company valued at more than $8 billion, according to Forbes. Though Gebbia no longer works at the company, he is its former chief product officer and current member of Airbnb's board of directors. 

Read Next: Uncertainty Rocks The Trump Trade: How ‘MAGA Seven’ Stocks Look Now

Notably, Gebbia also sits on the board of Tesla, Inc. (NASDAQ:TSLA) and is a close associate of Musk with the pair collaborating on various projects and investments in the past. 

Gebbia will work to update the government's paper-based retirement process and is expected to bring an unconventional view and entrepreneurial expertise to the department. 

ABNB Backlash: According to a Forbes report, hundreds of negative comments regarding Gebbia's involvement with DOGE have flooded Airbnb’s community portal with some hosts and guests threatening to leave the platform. 

Some of the notable comments included: "This makes me very sad as I can’t support a guy like that" and "I am extremely disturbed" to "Joe Gebbia cannot remain on the board" and "There are other options out there besides Airbnb."

Airbnb spokesperson, Christopher Nulty told Forbes, "Joe is joining DOGE in his personal capacity" and Gebbia's "personal views don’t reflect the views of Airbnb or Airbnb.org."

Additionally, Gebbia sold $30.4 million worth of Airbnb stock on Feb. 25, according to an SEC filing.  

Read Next:

  • Markets Tank After Trump Confirms More Tariffs: Here’s What Wall Street Is Saying

Image: Shutterstock

Continue Reading...

Popular

TradFi Meets Crypto: Stablecoins, Speed — And The New Market Order

The intersection of TradFi and crypto is reshaping finance, as revealed in a panel discussion at the Benzinga Fintech Day & Awards 2025.

You're Almost Out of Time to Place This "Debasement Trade" - Ad

Wall Street has been making headlines for piling into a strange new money move they're calling the "Debasement Trade"... And it could affect you and your money in a MAJOR way. According to Dr. David Eifrig the clock is ticking for you to get your money in the right place.

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

These are the 37 donors helping pay for Trump's $300 million White House ballroom

WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”

Speculative? Yes. But This Memecoin Has Serious Fundamentals. - Ad

Most memecoins are driven by hype-but this one might be different. Backed by a real use case and unexpected investor interest, our analysts believe it could emerge as one of the strongest performers in the coming cycle.

Latest opioid settlement plan with OxyContin maker Purdue and Sackler family getting few objections

NEW YORK (AP) — Lawyers representing OxyContin maker Purdue Pharma, branches of the Sackler family that own it, cities, states, counties, Native American tribes, people with addiction and others across the U.S. are expected to deliver a nearly unanimous message for a bankruptcy court judge Friday: Approve a plan to settle thousands of opioid-related lawsuits against the company.

California revokes 17,000 driver's licenses. But the state disputes it is over immigration concerns

California plans to revoke 17,000 commercial driver’s licenses given to immigrants after the Trump administration raised concerns about people in the country illegally receiving licenses to drive a semitruck or a bus. But Gov. Gavin Newsom said that isn't the reason.

The K7 Is Changing the Economics of Security - Ad

$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.

Trump no-show at big Asian economic forum may risk US reputation in region

GYEONGJU, South Korea (AP) — A hot mike caught U.S. President Donald Trump saying that his much-anticipated meeting Thursday , meant to settle the most important trade relationship in the world, would be “three, four hours” and he would then fly back to Washington.

IRS boosts contribution limits for 401(k) retirement plan savers

Americans will be allowed to contribute more of their money to 401(k) and similar retirement saving plans next year.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.

16 Stocks To Buy If You Want To Escape The AI Hype

Bank of America is pointing investors toward 16 overlooked stocks with strong fundamentals and no direct ties to the AI boom—offering a safer path beyond the hype.

Wall Street Enters Its Strongest Month: These 7 Stocks Often Crush It

November is historically Wall Street's strongest month. These 7 stocks often delivered standout gains in recent decades.

AI Meets Real-World Security with the K7 - Ad

Continuous patrols. Instant response. Zero fatigue. The K7 merges robotics and data to outperform humans in coverage, cost, and consistency and it's already live across the US.

The Real Reason This Analyst Still Calls Nebius His Favorite Neocloud Player

Nebius Group (NASDAQ: NBIS) reported strong Q3 results, boosting capacity & revenue guidance through 2026. Analyst reiterated Buy rating.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

Drone sightings disrupt flights at Belgium's main airport

BRUSSELS (AP) — Flights at Belgium’s main international airport remained disrupted on Wednesday after drone sightings overnight forced it to close temporarily and Prime Minister Bart De Wever called a meeting with senior ministers to discuss safety concerns.

America's Next Security Revolution Has Begun - Ad

Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.

What to know as the annual sign-up window for health insurance arrives

Higher prices, less help and all hang over health insurance markets as shoppers start looking for coverage this week.

Why Wall Street Is Piling Into the "Debasement Trade" - Ad

Wall Street has been making headlines lately for piling into a strange new money move. What they've dubbed the "Debasement Trade"... And it could affect you and your money in a MAJOR way. Dr. David Eifrig's latest warning deserves your attention.

Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.

Best ETF For The Critical Minerals Boom? Here Are Rare Earth Winners

Here's how VanEck's REMX and Amplify's BATT stack up in the fight for dominance over critical minerals and the clean energy supply chain.

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades

Terns Pharmaceuticals shares rise after TERN-701 shows a 75% response rate in the CML trial, and William Blair upgrades the stock to Outperform.

Huntington Bancshares buying Cadence Bank in $7.4 billion all-stock deal

Huntington Bancshares is buying regional bank Cadence Bank in an all-stock deal valued at $7.4 billion that will strengthen its position across the Southern U.S.

You're Almost Out of Time to Place This "Debasement Trade" - Ad

Wall Street has been making headlines for piling into a strange new money move they're calling the "Debasement Trade"... And it could affect you and your money in a MAJOR way. According to Dr. David Eifrig the clock is ticking for you to get your money in the right place.

Visa Q3 Preview: Could Credit Card Stock Be 'Poised To Snap Back To Its Winning Ways?'

Visa looks to piggyback off a strong earnings report from American Express and show strength in consumer spending.

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

Nearly 8 Million Shiba Inu Vanish After First SHIB ETF Filing Shakes Market

Nearly 8 million Shiba Inu (CRYPTO: SHIB) tokens have been incinerated following the inaugural filing of a Shiba Inu ETF, rekindling interest in the popular meme token.

Why Is Rein Therapeutics Stock Trading Higher On Monday?

Rein Therapeutics shares rise after the FDA lifts clinical hold on its Phase 2 RENEW trial for idiopathic pulmonary fibrosis treatment LTI-03.

Speculative? Yes. But This Memecoin Has Serious Fundamentals. - Ad

Most memecoins are driven by hype-but this one might be different. Backed by a real use case and unexpected investor interest, our analysts believe it could emerge as one of the strongest performers in the coming cycle.

NTSB says FAA was wrong not to require inspections of Learjet landing gear after Arizona crash

The National Transportation Safety Board wants the owners of nearly 2,000 Learjets — which have long been associated with the rich and famous — to urgently inspect their landing gear to make sure they won’t collapse as happened in a fatal crash in February involving a private jet owned by Mötley Crüe singer Vince Neil.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright systemtrading.ca
Privacy Policy | Terms of Service